David Webster Presents Body Vision Medical at LSI Europe '23
Body Vision Medical CEO, David Webster, takes the stand at LSI Europe '23 to discuss how LungVision is uniquely positioned to revolutionize the $5 billion lung cancer diagnostics and treatment industry by providing a clinically effective, easy to deploy and economical option for unlocking real-time, intraoperative imaging.